Kangmei Pharmaceutical Market Cap

Kangmei Pharmaceutical has a market cap or net worth of 23.65 billion as of April 28, 2026. Its market cap has decreased by -19.92% in one year.

Market Cap

23.65B

Enterprise Value

22.63B

Revenue

5.25B

Ranking

n/a

PE Ratio

2,289.64

Stock Price

1.73

Market Cap Chart

Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 23.65B, an increase of 817.09%. That is a compound annual growth rate of 9.22%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2026	23.92B	-9.42%
Dec 31, 2025	26.41B	-18.58%
Dec 31, 2024	32.44B	25.81%
Dec 29, 2023	25.79B	-15.45%
Dec 30, 2022	30.50B	-28.80%
Dec 31, 2021	42.84B	221.38%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Zhejiang Huahai Pharmaceutical	23.55B
Jiangsu Nhwa Pharmaceutical Co., LTD	22.79B
Hubei Jumpcan Pharmaceutical	24.63B
Tasly Pharmaceutical Group	22.57B
Chengdu Kanghong Pharmaceutical Group	22.56B
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	22.49B
Jilin Aodong Pharmaceutical Group	21.74B
Dizal (Jiangsu) Pharmaceutical	25.94B

Market Cap Rankings